Last updated on January 2012

Study to confirm the efficacy of Fesoterodine 4 mg compared to 8 mg.


Brief description of study

Study to confirm the efficacy of Fesoterodine 4 mg compared to 8 mg.

Detailed Study Description

The purpose of this study is to compare the effectiveness of two doses of a drug called Fesoterodine and placebo (a substance that contains no active ingredient but looks identical to the study drug) for overactive bladder. In order to achieve this evaluation in an unbiased manner, you will be randomly assigned to one of 3 groups: Fesoterodine 4 mg, Fesoterodine 8 mg, or Placebo.

Patient Inclusion Criteria:

  • Male or female over the age of 18
  • Overactive bladder for over 6 months
  • Subject must LEAK

Patient Exclusion Criteria:

  • A neurological condition
  • History of lower urinary tract or pelvic surgery
  • History of IC, bladder stones, or urinary retention
  • Bladder outlet obstruction

Clinical Study Identifier: TX135577

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Kristen Willinger

First Urology, PSC
Jeffersonville, IN USA
  Connect »